102 related articles for article (PubMed ID: 2879451)
1. Treatment of postprandial hypotension with a somatostatin analogue (SMS 201-995).
Hoeldtke RD; Boden G; O'Dorisio TM
Am J Med; 1986 Dec; 81(6B):83-7. PubMed ID: 2879451
[TBL] [Abstract][Full Text] [Related]
2. Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995.
Hoeldtke RD; O'Dorisio TM; Boden G
Lancet; 1986 Sep; 2(8507):602-5. PubMed ID: 2875321
[TBL] [Abstract][Full Text] [Related]
3. Effect of the somatostatin analogue SMS-201-995 on the adrenergic response to glucose ingestion in patients with postprandial hypotension.
Hoeldtke RD; Dworkin GE; Gaspar SR; Israel BC; Boden G
Am J Med; 1989 Jun; 86(6 Pt 1):673-7. PubMed ID: 2658575
[TBL] [Abstract][Full Text] [Related]
4. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus.
Spinas GA; Bock A; Keller U
Diabetes Care; 1985; 8(5):429-35. PubMed ID: 2865093
[TBL] [Abstract][Full Text] [Related]
5. Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995.
Hopman WP; Wolberink RG; Lamers CB; Van Tongeren JH
Ann Surg; 1988 Feb; 207(2):155-9. PubMed ID: 2893592
[TBL] [Abstract][Full Text] [Related]
6. Treatment of diabetic diarrhea and orthostatic hypotension with somatostatin analogue SMS 201-995.
Dudl RJ; Anderson DS; Forsythe AB; Ziegler MG; O'Dorisio TM
Am J Med; 1987 Sep; 83(3):584-8. PubMed ID: 2889358
[TBL] [Abstract][Full Text] [Related]
7. The effects of the somatostatin analogue SMS 201-995 on carbohydrate homeostasis of insulin-dependent diabetics as assessed by the artificial endocrine pancreas.
Hadjidakis DJ; Halvatsiotis PG; Ioannou YJ; Mavrokefalos PJ; Raptis SA
Diabetes Res Clin Pract; 1988 Jul; 5(2):91-8. PubMed ID: 2901329
[TBL] [Abstract][Full Text] [Related]
8. Glucose tolerance during long term treatment with a somatostatin analogue.
Verschoor L; Lamberts SW; Uitterlinden P; Del Pozo E
Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1327-8. PubMed ID: 2878704
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin analog SMS 201-995 and insulin needs in insulin-dependent diabetic patients studied by means of an artificial pancreas.
Rios MS; Navascues I; Saban J; Ordoñez A; Sevilla F; Del Pozo E
J Clin Endocrinol Metab; 1986 Nov; 63(5):1071-4. PubMed ID: 2876005
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
[TBL] [Abstract][Full Text] [Related]
11. Effect of a new long-acting somatostatin analogue (SMS 201-995) on glycemic and hormonal response to a mixed meal in acromegalic patients.
Candrina R; Gussago A; Giustina G
J Endocrinol Invest; 1988 Jan; 11(1):21-6. PubMed ID: 2896207
[TBL] [Abstract][Full Text] [Related]
12. Postprandial effects of SMS 201-995 on gut hormones and glucose tolerance.
Williams G; Fuessl H; Kraenzlin M; Bloom SR
Scand J Gastroenterol Suppl; 1986; 119():73-83. PubMed ID: 2876509
[TBL] [Abstract][Full Text] [Related]
13. Prevention of glucose-induced hypotension by the somatostatin analogue octreotide (SMS 201-995) in chronic autonomic failure: haemodynamic and hormonal changes.
Raimbach SJ; Cortelli P; Kooner JS; Bannister R; Bloom SR; Mathias CJ
Clin Sci (Lond); 1989 Dec; 77(6):623-8. PubMed ID: 2691174
[TBL] [Abstract][Full Text] [Related]
14. Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly.
Plewe G; Beyer J; Krause U; Neufeld M; del Pozo E
Lancet; 1984 Oct; 2(8406):782-4. PubMed ID: 6148524
[TBL] [Abstract][Full Text] [Related]
15. On the use of a new somatostatin analogue in the treatment of hypoglycaemia in patients with insulinoma.
Verschoor L; Uitterlinden P; Lamberts SW; Del Pozo E
Clin Endocrinol (Oxf); 1986 Nov; 25(5):555-60. PubMed ID: 2887309
[TBL] [Abstract][Full Text] [Related]
16. The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones.
George SR; Hegele RA; Burrow GN
Clin Invest Med; 1987 Jul; 10(4):309-15. PubMed ID: 2888554
[TBL] [Abstract][Full Text] [Related]
17. Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus.
Dimitriadis G; Tessari P; Gerich J
Metabolism; 1983 Oct; 32(10):987-92. PubMed ID: 6136893
[TBL] [Abstract][Full Text] [Related]
18. Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man.
Fuessl HS; Carolan G; Williams G; Bloom SR
Digestion; 1987; 36(2):101-7. PubMed ID: 2883059
[TBL] [Abstract][Full Text] [Related]
19. Effect of a long-acting somatostatin derivative SMS 201-995 (sandostatin) on glucose homeostasis in type I diabetes mellitus.
Navascues I; Gil J; Pascau C; Senén D; del Pozo E; Serrano-Ríos M
Horm Res; 1988; 29(2-3):92-4. PubMed ID: 2900205
[TBL] [Abstract][Full Text] [Related]
20. Effects of SMS 201-995 on intermediary metabolism and endocrine status in normal and diabetic humans.
Johnston DG; Davies RR; Alberti KG; Miller M; Turner SJ; Watson M; Orskov H
Am J Med; 1986 Dec; 81(6B):88-93. PubMed ID: 2879452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
